Millennium Management
LMNL

Millennium Management’s Liminal BioSciences Inc. Common Shares LMNL Stock Holding History

Millennium Management’s Portfolio LMNL Stock Details LMNL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,135
Closed -$4K – 7162
2022
Q4 		$4K Buy
+1,135
New +$5.19K ﹤0.01% 6344

Other funds holding LMNL

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
ECM
Estabrook Capital Management New York $685M AUM 26.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

Millennium Management's LMNL Position: Q1 2023 in Review

Millennium Management sold out of Liminal BioSciences Inc. Common Shares (LMNL) in Q1 2023, closing a stake of 1,135 shares — an estimated $4K sold.

Millennium Management first reported a position in LMNL in Q4 2022 and held it in 1 quarter. The position peaked at $4K in Q4 2022. 8 funds tracked by Wall St. Rank hold LMNL as of Q1 2023.

  • Millennium Management reported no remaining Liminal BioSciences Inc. Common Shares position as of Q1 2023 after selling out during the quarter.
  • Millennium Management sold 1,135 Liminal BioSciences Inc. Common Shares shares in Q1 2023, an estimated $4K.
  • Millennium Management first reported a position in Liminal BioSciences Inc. Common Shares in Q4 2022 and held it in 1 quarter.
  • Millennium Management's Liminal BioSciences Inc. Common Shares position peaked at $4K in Q4 2022.
  • 8 funds tracked by Wall St. Rank held Liminal BioSciences Inc. Common Shares as of Q1 2023.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.